Yüklüyor......
Sacubitril–valsartan in heart failure and multimorbidity patients
AIMS: The poor control of symptoms in patients with advanced heart failure with reduced ejection function (HFrEF) can limit the functionality of patients. Sacubitril–valsartan, compared with enalapril, has been shown to reduce mortality and hospitalization, and nowadays, there is still little eviden...
Kaydedildi:
| Yayımlandı: | ESC Heart Fail |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6165940/ https://ncbi.nlm.nih.gov/pubmed/30039930 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12338 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|